Skip to main content

Jorda Radek

Journals

ŘEZNÍČKOVÁ, E., A. POPA, T. GUCKÝ, M. ZATLOUKAL, L. HAVLICEK, V. BAZGIER, K. BERKA, R. JORDA, I. POPA, A. NASEREDDIN, C. JAFFE, V. KRYŠTOF, M. STRNAD
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro. Bioorganic and Medicinal Chemistry Letters. 2015, 25(11), 2298-2301, ISSN: 0960-894X, PMID: 25937014,
JORDA, R., L. HAVLICEK, I. MCNAE, M. WALKINSHAW, J. VOLLER, A. STURC, J. NAVRATILOVA, M. KUZMA, M. MISTRÍK, J. BÁRTEK, M. STRNAD, V. KRYŠTOF
Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity. Journal of Medicinal Chemistry. 2011, 54(8), 2980-2993, ISSN: 0022-2623, PMID: 21417417,
PAPRSKÁŘOVÁ, M., V. KRYŠTOF, R. JORDA, P. DŽUBÁK, M. HAJDÚCH, J. WESIERSKA-GADEK, M. STRNAD
Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine. Journal of Cellular Biochemistry. 2009, 107(3), 428-437, ISSN: 0730-2312, PMID: 19308936,